Your browser doesn't support javascript.
loading
Depth of remission is a prognostic factor for survival in patients with metastatic renal cell carcinoma.
Grünwald, Viktor; McKay, Rana R; Krajewski, Katherine M; Kalanovic, Daniel; Lin, Xun; Perkins, Julia J; Simantov, Ronit; Choueiri, Toni K.
Afiliação
  • Grünwald V; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • McKay RR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Krajewski KM; Department of Imaging, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Radiology, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA.
  • Kalanovic D; Pfizer Oncology, Pfizer Inc., La Jolla, CA, USA.
  • Lin X; Pfizer Oncology, Pfizer Inc., La Jolla, CA, USA.
  • Perkins JJ; Pfizer Oncology, Pfizer Inc., La Jolla, CA, USA.
  • Simantov R; Pfizer Oncology, Pfizer Inc., La Jolla, CA, USA.
  • Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: toni_choueiri@dfci.harvard.edu.
Eur Urol ; 67(5): 952-8, 2015 May.
Article em En | MEDLINE | ID: mdl-25577718

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Intervalo Livre de Doença / Recidiva Local de Neoplasia / Antineoplásicos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Intervalo Livre de Doença / Recidiva Local de Neoplasia / Antineoplásicos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article